Correlation Between Eton Pharmaceuticals and Travere Therapeutics
Can any of the company-specific risk be diversified away by investing in both Eton Pharmaceuticals and Travere Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eton Pharmaceuticals and Travere Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eton Pharmaceuticals and Travere Therapeutics, you can compare the effects of market volatilities on Eton Pharmaceuticals and Travere Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eton Pharmaceuticals with a short position of Travere Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eton Pharmaceuticals and Travere Therapeutics.
Diversification Opportunities for Eton Pharmaceuticals and Travere Therapeutics
0.87 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Eton and Travere is 0.87. Overlapping area represents the amount of risk that can be diversified away by holding Eton Pharmaceuticals and Travere Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Travere Therapeutics and Eton Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eton Pharmaceuticals are associated (or correlated) with Travere Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Travere Therapeutics has no effect on the direction of Eton Pharmaceuticals i.e., Eton Pharmaceuticals and Travere Therapeutics go up and down completely randomly.
Pair Corralation between Eton Pharmaceuticals and Travere Therapeutics
Given the investment horizon of 90 days Eton Pharmaceuticals is expected to generate 1.33 times more return on investment than Travere Therapeutics. However, Eton Pharmaceuticals is 1.33 times more volatile than Travere Therapeutics. It trades about 0.39 of its potential returns per unit of risk. Travere Therapeutics is currently generating about 0.1 per unit of risk. If you would invest 842.00 in Eton Pharmaceuticals on August 29, 2024 and sell it today you would earn a total of 403.00 from holding Eton Pharmaceuticals or generate 47.86% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Eton Pharmaceuticals vs. Travere Therapeutics
Performance |
| Timeline |
| Eton Pharmaceuticals |
| Travere Therapeutics |
Eton Pharmaceuticals and Travere Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eton Pharmaceuticals and Travere Therapeutics
The main advantage of trading using opposite Eton Pharmaceuticals and Travere Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eton Pharmaceuticals position performs unexpectedly, Travere Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Travere Therapeutics will offset losses from the drop in Travere Therapeutics' long position.| Eton Pharmaceuticals vs. Phibro Animal Health | Eton Pharmaceuticals vs. Procaps Group SA | Eton Pharmaceuticals vs. Amphastar P | Eton Pharmaceuticals vs. Alkermes Plc |
| Travere Therapeutics vs. Cytokinetics | Travere Therapeutics vs. Ventyx Biosciences | Travere Therapeutics vs. Cogent Biosciences | Travere Therapeutics vs. Nuvalent |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |